Antti I. Nykänen
Transplantation Laboratory
Haartman Institute
PO Box 21 (Haartmaninkatu 3)
FIN-00014
Finland
Name/email consistency: high
- Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection. Tuuminen, R., Syrjälä, S., Krebs, R., Keränen, M.A., Koli, K., Abo-Ramadan, U., Neuvonen, P.J., Tikkanen, J.M., Nykänen, A.I., Lemström, K.B. Circulation (2011)
- Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Nykänen, A.I., Sandelin, H., Krebs, R., Keränen, M.A., Tuuminen, R., Kärpänen, T., Wu, Y., Pytowski, B., Koskinen, P.K., Ylä-Herttuala, S., Alitalo, K., Lemström, K.B. Circulation (2010)
- Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy. Nykänen, A.I., Pajusola, K., Krebs, R., Keränen, M.A., Raisky, O., Koskinen, P.K., Alitalo, K., Lemström, K.B. Circ. Res. (2006)
- Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Nykänen, A.I., Krebs, R., Tikkanen, J.M., Raisky, O., Sihvola, R., Wood, J., Koskinen, P.K., Lemström, K.B. Transplantation (2005)